Zuellig Pharma, Eli Lilly secure Singapore clearance for Cialis deal
MLex Summary: The Competition and Consumer Commission of Singapore has cleared Zuellig Pharma Holdings’ proposed acquisition of certain assets from Eli Lilly and Company, including rights to manufacture, market and distribute...To view the full article, register now.
Already a subscriber? Click here to view full article